71 related articles for article (PubMed ID: 22989483)
1. Modulation of osteoclastic migration by metabolism of 25OH-vitamin D3.
Kogawa M; Findlay DM; Anderson PH; Atkins GJ
J Steroid Biochem Mol Biol; 2013 Jul; 136():59-61. PubMed ID: 22989483
[TBL] [Abstract][Full Text] [Related]
2. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts.
Kogawa M; Anderson PH; Findlay DM; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):277-80. PubMed ID: 20304055
[TBL] [Abstract][Full Text] [Related]
4. Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice.
Reinke DC; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():353-360. PubMed ID: 26639637
[TBL] [Abstract][Full Text] [Related]
5. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
6. Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.
van't Hof RJ; Tuinenburg-Bol Raap AC; Nijweide PJ
Int J Exp Pathol; 1995 Jun; 76(3):205-14. PubMed ID: 7547432
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.
Takahashi N
J Steroid Biochem Mol Biol; 2013 Jul; 136():171-4. PubMed ID: 23220095
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1β-mediated signaling pathways.
Gramoun A; Azizi N; Sodek J; Heersche JN; Nakchbandi I; Manolson MF
J Cell Biochem; 2010 Nov; 111(4):1020-34. PubMed ID: 20672308
[TBL] [Abstract][Full Text] [Related]
9. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration.
Brazier H; Pawlak G; Vives V; Blangy A
Int J Biochem Cell Biol; 2009 Jun; 41(6):1391-401. PubMed ID: 19135548
[TBL] [Abstract][Full Text] [Related]
10. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts.
de Vries TJ; Mullender MG; van Duin MA; Semeins CM; James N; Green TP; Everts V; Klein-Nulend J
Mol Cancer Res; 2009 Apr; 7(4):476-88. PubMed ID: 19372577
[TBL] [Abstract][Full Text] [Related]
11. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
[TBL] [Abstract][Full Text] [Related]
13. Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate.
Löwik CW; van der Pluijm G; van der Wee-Pals LJ; van Treslong-De Groot HB; Bijvoet OL
J Bone Miner Res; 1988 Apr; 3(2):185-92. PubMed ID: 3213614
[TBL] [Abstract][Full Text] [Related]
14. Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.
Samanna V; Ma T; Mak TW; Rogers M; Chellaiah MA
J Cell Physiol; 2007 Dec; 213(3):710-20. PubMed ID: 17508356
[TBL] [Abstract][Full Text] [Related]
15. Generation of osteoclasts in cultures of rabbit bone marrow and spleen cells.
Fuller K; Chambers TJ
J Cell Physiol; 1987 Sep; 132(3):441-52. PubMed ID: 3308907
[TBL] [Abstract][Full Text] [Related]
16. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue.
Hattersley G; Chambers TJ
J Cell Physiol; 1990 Jan; 142(1):201-9. PubMed ID: 2153687
[TBL] [Abstract][Full Text] [Related]
17. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
[TBL] [Abstract][Full Text] [Related]
18. Bone cells required for osteoclastic resorption but not for osteoclastic differentiation.
Owens JM; Gallagher AC; Chambers TJ
Biochem Biophys Res Commun; 1996 May; 222(2):225-9. PubMed ID: 8670187
[TBL] [Abstract][Full Text] [Related]
19. Phorbol myristate acetate stimulates osteoclast formation in 1 alpha,25-dihydroxyvitamin D3-primed mouse embryonic calvarial cells by a prostaglandin-dependent mechanism.
Amano S; Hanazawa S; Kawata Y; Nakada Y; Miyata Y; Kitano S
J Bone Miner Res; 1994 Apr; 9(4):465-72. PubMed ID: 8030434
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]